Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma

impact on allogeneic haematopoietic stem cell transplantation

Takashi Ishida, Tatsuro Jo, Shigeki Takemoto, Hitoshi Suzushima, Youko Suehiro, Ilseung Choi, Makoto Yoshimitsu, Yoshio Saburi, Kisato Nosaka, Atae Utsunomiya, Yukio Kobayashi, Kazuhito Yamamoto, Hiroshi Fujiwara, Kenji Ishitsuka, Shinichiro Yoshida, Naoya Taira, Kazunori Imada, Koji Kato, Yukiyoshi Moriuchi, Kenichi Yoshimura & 3 others Takeshi Takahashi, Kensei Tobinai, Ryuzo Ueda

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)479-483
Number of pages5
JournalBritish Journal of Haematology
Volume184
Issue number3
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Adult T Cell Leukemia Lymphoma
Hematopoietic Stem Cell Transplantation
Drug Therapy
mogamulizumab

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma : impact on allogeneic haematopoietic stem cell transplantation. / Ishida, Takashi; Jo, Tatsuro; Takemoto, Shigeki; Suzushima, Hitoshi; Suehiro, Youko; Choi, Ilseung; Yoshimitsu, Makoto; Saburi, Yoshio; Nosaka, Kisato; Utsunomiya, Atae; Kobayashi, Yukio; Yamamoto, Kazuhito; Fujiwara, Hiroshi; Ishitsuka, Kenji; Yoshida, Shinichiro; Taira, Naoya; Imada, Kazunori; Kato, Koji; Moriuchi, Yukiyoshi; Yoshimura, Kenichi; Takahashi, Takeshi; Tobinai, Kensei; Ueda, Ryuzo.

In: British Journal of Haematology, Vol. 184, No. 3, 01.02.2019, p. 479-483.

Research output: Contribution to journalLetter

Ishida, T, Jo, T, Takemoto, S, Suzushima, H, Suehiro, Y, Choi, I, Yoshimitsu, M, Saburi, Y, Nosaka, K, Utsunomiya, A, Kobayashi, Y, Yamamoto, K, Fujiwara, H, Ishitsuka, K, Yoshida, S, Taira, N, Imada, K, Kato, K, Moriuchi, Y, Yoshimura, K, Takahashi, T, Tobinai, K & Ueda, R 2019, 'Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation', British Journal of Haematology, vol. 184, no. 3, pp. 479-483. https://doi.org/10.1111/bjh.15123
Ishida, Takashi ; Jo, Tatsuro ; Takemoto, Shigeki ; Suzushima, Hitoshi ; Suehiro, Youko ; Choi, Ilseung ; Yoshimitsu, Makoto ; Saburi, Yoshio ; Nosaka, Kisato ; Utsunomiya, Atae ; Kobayashi, Yukio ; Yamamoto, Kazuhito ; Fujiwara, Hiroshi ; Ishitsuka, Kenji ; Yoshida, Shinichiro ; Taira, Naoya ; Imada, Kazunori ; Kato, Koji ; Moriuchi, Yukiyoshi ; Yoshimura, Kenichi ; Takahashi, Takeshi ; Tobinai, Kensei ; Ueda, Ryuzo. / Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma : impact on allogeneic haematopoietic stem cell transplantation. In: British Journal of Haematology. 2019 ; Vol. 184, No. 3. pp. 479-483.
@article{082cf77e4552454ab924da3b14bfdc52,
title = "Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation",
author = "Takashi Ishida and Tatsuro Jo and Shigeki Takemoto and Hitoshi Suzushima and Youko Suehiro and Ilseung Choi and Makoto Yoshimitsu and Yoshio Saburi and Kisato Nosaka and Atae Utsunomiya and Yukio Kobayashi and Kazuhito Yamamoto and Hiroshi Fujiwara and Kenji Ishitsuka and Shinichiro Yoshida and Naoya Taira and Kazunori Imada and Koji Kato and Yukiyoshi Moriuchi and Kenichi Yoshimura and Takeshi Takahashi and Kensei Tobinai and Ryuzo Ueda",
year = "2019",
month = "2",
day = "1",
doi = "10.1111/bjh.15123",
language = "English",
volume = "184",
pages = "479--483",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma

T2 - impact on allogeneic haematopoietic stem cell transplantation

AU - Ishida, Takashi

AU - Jo, Tatsuro

AU - Takemoto, Shigeki

AU - Suzushima, Hitoshi

AU - Suehiro, Youko

AU - Choi, Ilseung

AU - Yoshimitsu, Makoto

AU - Saburi, Yoshio

AU - Nosaka, Kisato

AU - Utsunomiya, Atae

AU - Kobayashi, Yukio

AU - Yamamoto, Kazuhito

AU - Fujiwara, Hiroshi

AU - Ishitsuka, Kenji

AU - Yoshida, Shinichiro

AU - Taira, Naoya

AU - Imada, Kazunori

AU - Kato, Koji

AU - Moriuchi, Yukiyoshi

AU - Yoshimura, Kenichi

AU - Takahashi, Takeshi

AU - Tobinai, Kensei

AU - Ueda, Ryuzo

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85041669463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041669463&partnerID=8YFLogxK

U2 - 10.1111/bjh.15123

DO - 10.1111/bjh.15123

M3 - Letter

VL - 184

SP - 479

EP - 483

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -